https://www.selleckchem.com/EGFR(HER).html
ed-effects model showed no significant treatment effect (IV vs UC) over 12 months (P=.06). However, participants with higher baseline HbA and those in the first time period experienced greater improvements in HbA . Both groups reported similar improvements in treatment satisfaction throughout the study. Patients enrolled in the diabetes remote monitoring program intervention experienced improvements in HbA and treatment satisfaction similar to usual care at a specialty diabetes center. Future studies on diabetes remote monitoring programs shou